Monthly Retail Trade Sales Report from Census Bureau Highlights Consumer Spending Trends US Payrolls Surge Past Expectations in April Yet Underlying Red Flags Emerge Global Markets Dip as Middle East Tensions Fuel Oil Price Surge US Growth Revised Downward Elon Musk Clarifies SpaceXAnthropic AI Deal Agreement Less Expansive Than Speculated Nokia Secures UK Appeal Victory Blocking Acer and Asus Video Patent Lawsuits Indian Benchmarks Surge as Sensex Soars Over 1000 Points Nifty Crosses 24000 on Easing Crude and Global Optimism CODX Q1 2026 Earnings EPS Falls Short of Estimates Stock Surges on Speculative Optimism POET Q1 2026 Earnings EPS Misses Expectations as Revenue Remains Unreported VLYPO Q1 2026 Earnings Preferred EPS Beats Estimates as Bank Navigates Steady Earnings Environment OPKO Health Q1 2026 Earnings Narrowly Beats EPS Estimates Amid Operational Focus OEC Q1 2026 Earnings Significant EPS Miss Amid Positive Stock Reaction CLMB Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction Healthcare Triangle HCTI Edges Higher Consolidating Between Support and Resistance Terrestrial Energy Inc IMSR Surges Over 8 on Renewed Investor Interest Banco Latinoamericano de Comercio Exterior BLX Slips 227 Key Support and Resistance in Focus BlackRock Credit Allocation Income Trust BTZ Edges Higher as Income Investors Test Resistance Dorchester Minerals DMLP Slides 345 as Energy Sector Pressures Weigh on Royalty Income Oura HealthTracking Smart Ring Maker Files Confidentially for IPO WTTR Q1 2026 Earnings EPS Surges 106 Above Estimates as Water Solutions Sector Strengthens UK Service Sector Activity Declines Sharply Perfect Storm of Political Uncertainty and Iran Conflict Weighs on Businesses HLX Q1 2026 Earnings Earnings Miss Weighs on Shares as Helix Energy Posts WiderThanExpected Loss AMTX Q1 2026 Earnings EPS Misses Estimates as Stock Surges on Strategic Progress Goldman Sachs Russias Crude Exports Remain Resilient Despite Latest US Sanctions IRS Q1 2026 Earnings Significant Loss Reported Amidst Argentine Economic Challenges Aytu BioPharma Gains 164 as Stock Tests Key Resistance at 228